Mr William Richard Gelinas, DO | |
11535 W Emerald Oaks Dr, Crystal River, FL 34428-2815 | |
(352) 794-6191 | |
(352) 794-6193 |
Full Name | Mr William Richard Gelinas |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 37 Years |
Location | 11535 W Emerald Oaks Dr, Crystal River, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851397749 | NPI | - | NPPES |
260728000 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 058292 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bayfront Health Seven Rivers | Crystal river, FL | Hospital |
Entity Name | Suncoast Vascular & General Surgery Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992183545 PECOS PAC ID: 5698089019 Enrollment ID: O20150729009681 |
News Archive
Adecco Group North America's latest American Workplace Insights Survey finds that 77% of workers(1) think their workplace will be impacted in some way by the swine flu.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.
A recent study in North Carolina found that in the first two weeks after being released from prison, former inmates were 40 times more likely to die of an opioid overdose than someone in the general population.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mr William Richard Gelinas, DO 11535 W Emerald Oaks Dr, Crystal River, FL 34428-2815 Ph: (352) 794-6191 | Mr William Richard Gelinas, DO 11535 W Emerald Oaks Dr, Crystal River, FL 34428-2815 Ph: (352) 794-6191 |
News Archive
Adecco Group North America's latest American Workplace Insights Survey finds that 77% of workers(1) think their workplace will be impacted in some way by the swine flu.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.
A recent study in North Carolina found that in the first two weeks after being released from prison, former inmates were 40 times more likely to die of an opioid overdose than someone in the general population.
› Verified 9 days ago